Now, there could be another alternative, in the form of eye drops administered daily, according to AbbVie's Allergan subsidiary, which reported new phase 3 data for its pilocarpine formulation ...

Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a ...

Xiidra, in a 5% solution formulation, is indicated for signs and symptoms of dry eye disease in adults, and is the only prescription eye drop approved ... although Allergan is developing a rival.

Here's the story of how Allergan went from a small Los Angeles company known for making eye-drops to an Ireland-domiciled drug giant with a market value of $123 billion, and potentially 2015's ...

The move put Allergan in a spot to develop more branded drugs in areas like eye care, aesthetics, gastroenterology (dealing with the stomach and intestines), and women's health. Here's a shot of ...